. Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting. J Alzheimers Dis. 2020;74(2):473-490. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(62)
511.6 ± 197.3
pg/mL §
ELISA;
;
Fujirebio
McKhann et al., 2011
Aβ42
(CSF)
CTRL-
CNC
(27)
840.3 ± 196
pg/mL §
ELISA;
;
Fujirebio
Aβ42
(CSF)
FTD-
bvFTD, svPPA, nfvPPA, FTD with motor neuron disease
(14)
809.6 ± 286.4
pg/mL §
ELISA;
;
Fujirebio
Rascovsky et al., 2011; Gorno-Tempini et al., 2011
Aβ42
(CSF)
NPH
(27)
678 ± 216.4
pg/mL §
ELISA;
;
Fujirebio
tau-p181
(CSF)
AD
(62)
80.5 ± 34.9
pg/mL §
ELISA;
;
Fujirebio
McKhann et al., 2011
tau-p181
(CSF)
CTRL-
CNC
(27)
40.8 ± 11.7
pg/mL §
ELISA;
;
Fujirebio
tau-p181
(CSF)
FTD-
bvFTD, svPPA, nfvPPA, FTD with motor neuron disease
(14)
50 ± 28.6
pg/mL §
ELISA;
;
Fujirebio
Rascovsky et al., 2011; Gorno-Tempini et al., 2011
tau-p181
(CSF)
NPH
(27)
34.2 ± 16.2
pg/mL §
ELISA;
;
Fujirebio
tau-total
(CSF)
AD
(62)
537.9 ± 327.6
pg/mL §
ELISA;
;
Fujirebio
McKhann et al., 2011
tau-total
(CSF)
CTRL-
CNC
(27)
192.1 ± 72.6
pg/mL §
ELISA;
;
Fujirebio
tau-total
(CSF)
FTD-
bvFTD, svPPA, nfvPPA, FTD with motor neuron disease
(14)
307.9 ± 186
pg/mL §
ELISA;
;
Fujirebio
Rascovsky et al., 2011; Gorno-Tempini et al., 2011
tau-total
(CSF)
NPH
(27)
178.5 ± 104.2
pg/mL §
ELISA;
;
Fujirebio

§ Data supplied to Alzforum by author

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.